Published in Blood Weekly, September 18th, 2003
"Current data demonstrate a lack of support for allogeneic transfusion as a reliable means of delivering oxygen," scientists in New Jersey explained.
"For the ICU patient tolerance of anemia along with aggressive erythropoitin plus iron therapies can restore hemoglobin levels to normal earlier and with fewer morbidities and possibly enhanced survival than by allogeneic transfusion," according to A. Shander and colleagues at Englewood Hospital.
"Additional evidence on anemia treatment comes from case report studies where transfusions are prohibited and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.